Clinical Trials of Immune Checkpoint Inhibitors as FIrst Line Therapy for Advanced NSCLC

Nov 18, 2015 · 5m 43s
Clinical Trials of Immune Checkpoint Inhibitors as FIrst Line Therapy for Advanced NSCLC
Description
Dr. Jack West summarizes the rationale for testing immune checkpoint inhibitors as a first line treatment for patients with advanced NSCLC and highlights details of two trials testing this question.
Information
Author cancerGRACE
Organization cancerGRACE
Website -
Tags

Looks like you don't have any active episode

Browse Spreaker Catalogue to discover great new content

Current

Podcast Cover

Looks like you don't have any episodes in your queue

Browse Spreaker Catalogue to discover great new content

Next Up

Episode Cover Episode Cover

It's so quiet here...

Time to discover new episodes!

Discover
Your Library
Search